Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-01 07:40:31 - browse：81838

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Poor hospice wound care hurts patients and families

WSS

FDA clears Verve to begin U.S. study of gene

STAT Summit: How researchers deal with rejection

STAT Readout: Friday, Oct. 20 biotech updates

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Morphosys mixed study results for blood cancer drug

STAT Summit: Meghan O’Rourke on making chronic illness visible

leisure time

Wikipedia

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Astellas still sees hope in its gene therapy after four deaths

Affirmative action in medical school literally saved lives

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Trump demands the U.S. pay no more for drugs than other countries … again

Gain of function research would be limited under House proposal

Cancer drug shortages should be causing more outrage

NYU radiologists take on the challenge of expensive MRI machines

Trump demands the U.S. pay no more for drugs than other countries … again

STAT Readout: Friday, Oct. 20 biotech updates

focus

FDA clears Verve to begin U.S. study of gene

Smaller biotechs seek to piggyback on weight loss drug boom

CZI to create biohub to build anti

Roivant's CEO is a star, but biotech's black hole persists

The problems with dementia villages

Does good food count as health care? Study aims to find out

leisure time

hotspot

leisure time

Wikipedia